SANTA MONICA, Calif. Feb. 14, 2011 Derycz Scientific, Inc. $3 million $2.50 $3.00 $3 million
Derycz intends to use the proceeds of the private placement for working capital purposes. T.R. Winston & Company, LLC served as the exclusive placement agent for the transaction.
the United States February 15, 2011
About Derycz Scientific®
Certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company’s products in the market; the Company’s success in obtaining new customers; the Company’s success in technology and product development; the Company’s ability to execute its business model and strategic plans; and all the risks and related information described from time to time in the Company’s filings with the Securities and Exchange Commission ("SEC"), including the financial statements and related information contained in the Company’s Annual Report on Form 10-K. The Company assumes no obligation to update the cautionary information in this release.
SOURCE Derycz Scientific, Inc.